OTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷 Benzinga Digital Content Studio

Digital Asset Direct by Organicell Regenerative Medicine, Inc.

Detroit, MI | November 22, 2022 11:33 AM Eastern Standard Time

Organicell Regenerative Medicine, Inc. (OTCMKTS: OCEL) has announced that their long COVID Clinical Trial is now officially active with enrollment to test the efficacy of their naturally derived therapeutic, Zofin! Learn more about this exciting development in this video! Organicell is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and the provision of other related services. Visit Organicell here 👉 https://organicell.com/

Contact Details

Organicell Investor Relations

IR@organicell.com

Company Website

https://organicell.com/